ADCIRCA for Pulmonary arterial hypertension: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 20 adverse event reports in the FDA FAERS database where ADCIRCA was used for Pulmonary arterial hypertension.
Most Reported Side Effects for ADCIRCA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Dyspnoea | 17 | 18.1% | 2 | 14 |
| Headache | 13 | 13.8% | 0 | 7 |
| Death | 10 | 10.6% | 10 | 2 |
| Anaemia | 7 | 7.5% | 0 | 7 |
| Malaise | 7 | 7.5% | 0 | 4 |
| Oedema peripheral | 7 | 7.5% | 2 | 5 |
| Pneumonia | 7 | 7.5% | 0 | 6 |
| Abdominal distension | 6 | 6.4% | 2 | 3 |
| Fluid retention | 5 | 5.3% | 1 | 3 |
| Nasal congestion | 5 | 5.3% | 0 | 0 |
| Nausea | 5 | 5.3% | 0 | 3 |
Other Indications for ADCIRCA
Other Drugs Used for Pulmonary arterial hypertension
TREPROSTINIL (72,609)
MACITENTAN (29,246)
AMBRISENTAN (27,852)
BOSENTAN (12,387)
SELEXIPAG (11,861)
RIOCIGUAT (9,158)
EPOPROSTENOL (8,508)
TADALAFIL (7,679)
SILDENAFIL (5,239)
ILOPROST (2,828)